Renato Monteiro is professor of Immunology at Paris Diderot University and head of the Center for Research on Inflammation – INSERM U1149 & CNRS ERL8252 located at Bichat Hospital campus in Paris. After obtaining his medical degree in Brazil and then completing a residency in nephrology, he moved to Paris in 1982 to study nephrology at the Necker Hospital under the mentoring of Professor Jean Berger. Prof. Monteiro was awarded the 1986 Prize of the French Society of Nephrology for his work on IgA nephropathy, notably for the identification of abnormal IgA in Berger’s disease. He later studied immunology at the University of Birmingham in Alabama with Professor Max Cooper. Prof. Monteiro’s work in Prof. Cooper’s lab led to the identification of the IgA Fc receptor I (CD89). He defended his PhD thesis in immunology in 1993 at Paris Diderot University.
 
Professor  Monteiro  made  important  discoveries  in  the  field  of  IgA  and  Fcα  receptors.   His  research  group  identified  CD71  transferrin  receptor  as  an  IgA1  receptor  and  pioneered   work  in  involvement  of  CD89  and  CD71  in  diseases  involving  the  IgA  system  such  as  IgA   nephropathy,  Henoch-Schönlein  purpura,  spondylitis,  alcoholic  cirrhosis,  and  celiac  disease.   His  team  identified  an  unsuspected  function  for  CD89  and  SIGNR1,  and  beyond,  a  new  role   for  these  molecules  as  dampers  of  the  immune  system.  They  demonstrated  for  the  first   time  that  CD89  can  play  an  inhibitory  role  of  cell  activation  besides  its  known  role  in  cell   activation.  When  occupied  by  monomeric  IgA  or  when  targeted  by  anti-receptor  Fab   fragment,  CD89  can  promote  sustained  inhibition  of  cell  activation  opening  new   therapeutic  approaches.  Prof.  Monteiro  was  awarded  the  2010  Prize  of  the  French  Society   of  Immunology  for  his  work  on  CD89.
